183 related articles for article (PubMed ID: 19120350)
21. [Down syndrome and acute lymphoblastic leukemia].
Okamoto Y
Rinsho Ketsueki; 2021; 62(10):1465-1473. PubMed ID: 34732618
[TBL] [Abstract][Full Text] [Related]
22. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.
Buitenkamp TD; Izraeli S; Zimmermann M; Forestier E; Heerema NA; van den Heuvel-Eibrink MM; Pieters R; Korbijn CM; Silverman LB; Schmiegelow K; Liang DC; Horibe K; Arico M; Biondi A; Basso G; Rabin KR; Schrappe M; Cario G; Mann G; Morak M; Panzer-Grümayer R; Mondelaers V; Lammens T; Cavé H; Stark B; Ganmore I; Moorman AV; Vora A; Hunger SP; Pui CH; Mullighan CG; Manabe A; Escherich G; Kowalczyk JR; Whitlock JA; Zwaan CM
Blood; 2014 Jan; 123(1):70-7. PubMed ID: 24222333
[TBL] [Abstract][Full Text] [Related]
23. The acute lymphoblastic leukemia of Down Syndrome - Genetics and pathogenesis.
Izraeli S
Eur J Med Genet; 2016 Mar; 59(3):158-61. PubMed ID: 26631987
[TBL] [Abstract][Full Text] [Related]
24. A novel somatic JAK2 kinase-domain mutation in pediatric acute lymphoblastic leukemia with rapid on-treatment development of LOH.
Sadras T; Heatley SL; Kok CH; McClure BJ; Yeung D; Hughes TP; Sutton R; Ziegler DS; White DL
Cancer Genet; 2017 Oct; 216-217():86-90. PubMed ID: 29025600
[TBL] [Abstract][Full Text] [Related]
25. Down syndrome and acute lymphoblastic leukaemia.
Whitlock JA
Br J Haematol; 2006 Dec; 135(5):595-602. PubMed ID: 17054672
[TBL] [Abstract][Full Text] [Related]
26. Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries.
Lundin C; Forestier E; Klarskov Andersen M; Autio K; Barbany G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Johansson B; ; ;
J Hematol Oncol; 2014 Apr; 7():32. PubMed ID: 24726034
[TBL] [Abstract][Full Text] [Related]
27. Child and adolescent Down syndrome-associated leukaemia: the Irish experience.
O'Rafferty C; Kelly J; Storey L; Ryan C; O'Marcaigh A; Smith O
Ir J Med Sci; 2015 Dec; 184(4):877-82. PubMed ID: 25344131
[TBL] [Abstract][Full Text] [Related]
28. The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome.
Lee P; Bhansali R; Izraeli S; Hijiya N; Crispino JD
Leukemia; 2016 Sep; 30(9):1816-23. PubMed ID: 27285583
[TBL] [Abstract][Full Text] [Related]
29. Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.
Zawitkowska J; Odój T; Drabko K; Zaucha-Prażmo A; Rudnicka J; Romiszewski M; Matysiak M; Kwiecińska K; Ćwiklińska M; Balwierz W; Owoc-Lempach J; Derwich K; Wachowiak J; Niedźwiecki M; Adamkiewicz-Drożyńska E; Trelińska J; Młynarski W; Kołtan A; Wysocki M; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Ociepa T; Urasiński T; Mizia-Malarz A; Sobol-Milejska G; Karolczyk G; Kowalczyk J
Pediatr Hematol Oncol; 2017 May; 34(4):199-205. PubMed ID: 29040012
[TBL] [Abstract][Full Text] [Related]
30. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
[TBL] [Abstract][Full Text] [Related]
31. RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia.
Koschut D; Ray D; Li Z; Giarin E; Groet J; Alić I; Kham SK; Chng WJ; Ariffin H; Weinstock DM; Yeoh AE; Basso G; Nižetić D
Oncogene; 2021 Jan; 40(4):746-762. PubMed ID: 33247204
[TBL] [Abstract][Full Text] [Related]
32. The common TEL/AML1 rearrangement does not represent a frequent event in acute lymphoblastic leukaemia occuring in children with Down syndrome.
Lanza C; Volpe G; Basso G; Gottardi E; Perfetto F; Cilli V; Spinelli M; Ricotti E; Guerrasio A; Madon E; Saglio G
Leukemia; 1997 Jun; 11(6):820-1. PubMed ID: 9177434
[TBL] [Abstract][Full Text] [Related]
33. JAK/STAT signaling in hematological malignancies.
Vainchenker W; Constantinescu SN
Oncogene; 2013 May; 32(21):2601-13. PubMed ID: 22869151
[TBL] [Abstract][Full Text] [Related]
34. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
Forestier E; Izraeli S; Beverloo B; Haas O; Pession A; Michalová K; Stark B; Harrison CJ; Teigler-Schlegel A; Johansson B
Blood; 2008 Feb; 111(3):1575-83. PubMed ID: 17971484
[TBL] [Abstract][Full Text] [Related]
36. Acute Leukemia in Down Syndrome Children in Hong Kong: Retrospective Review.
Lam GK; Leung AW; Ha SY; Luk CW; Li CH; Ling SC; Chiang AK; Li CK
J Pediatr Hematol Oncol; 2016 Mar; 38(2):102-6. PubMed ID: 26808367
[TBL] [Abstract][Full Text] [Related]
37. High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome.
Lundin C; Hjorth L; Behrendtz M; Nordgren A; Palmqvist L; Andersen MK; Biloglav A; Forestier E; Paulsson K; Johansson B
Genes Chromosomes Cancer; 2012 Feb; 51(2):196-206. PubMed ID: 22072402
[TBL] [Abstract][Full Text] [Related]
38. Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
Norton A; Fisher C; Liu H; Wen Q; Mundschau G; Fuster JL; Hasle H; Zeller B; Webb DK; O'Marcaigh A; Sorrell A; Hilden J; Gamis A; Crispino JD; Vyas P
Blood; 2007 Aug; 110(3):1077-9. PubMed ID: 17644747
[No Abstract] [Full Text] [Related]
39. Array comparative genome hybridization analysis of acute lymphoblastic leukaemia and acute megakaryoblastic leukaemia in patients with Down syndrome.
Lo KC; Chalker J; Strehl S; Neat M; Smith O; Dastugue N; Kearney L; Izraeli S; Kempski H; Cowell JK
Br J Haematol; 2008 Sep; 142(6):934-45. PubMed ID: 18557744
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.
Meyr F; Escherich G; Mann G; Klingebiel T; Kulozik A; Rossig C; Schrappe M; Henze G; von Stackelberg A; Hitzler J
Br J Haematol; 2013 Jul; 162(1):98-106. PubMed ID: 23594030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
